2023 Q2 Form 10-Q Financial Statement

#000121390023038233 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $71.00K $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.080M $3.833M $3.120M
YoY Change 301.41% 114.49% 24.65%
% of Gross Profit
Research & Development $2.000K $0.00 $30.00K
YoY Change -94.44% -100.0% -63.41%
% of Gross Profit
Depreciation & Amortization $20.00K $7.000K
YoY Change
% of Gross Profit
Operating Expenses $9.082M $3.834M $3.140M
YoY Change 295.21% 0.82% 21.47%
Operating Profit -$9.011M -$3.834M
YoY Change 292.12% 0.82%
Interest Expense $560.0K $70.00K -$4.110M
YoY Change -120.15% -65.69% -630.32%
% of Operating Profit
Other Income/Expense, Net $348.0K $72.00K $0.00
YoY Change -112.52% 12.5%
Pretax Income -$8.660M -$3.760M -$7.260M
YoY Change 70.57% 6.36% 301.1%
Income Tax
% Of Pretax Income
Net Earnings -$8.663M -$3.762M -$7.260M
YoY Change 70.63% 6.42% 301.1%
Net Earnings / Revenue -12201.41%
Basic Earnings Per Share -$1.79 -$0.71
Diluted Earnings Per Share -$1.79 -$0.71 -$1.32
COMMON SHARES
Basic Shares Outstanding 4.593M shares 4.841M shares 5.485M shares
Diluted Shares Outstanding 4.827M shares 5.306M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.27M $33.93M $40.30M
YoY Change -40.18% -50.52% -51.71%
Cash & Equivalents $3.598M $9.533M $33.17M
Short-Term Investments $20.68M $24.39M $7.130M
Other Short-Term Assets $7.800M $4.300M $900.0K
YoY Change 3879.59% -79.81% 103.62%
Inventory
Prepaid Expenses $301.0K
Receivables $6.300M $6.500M $7.500M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $38.42M $44.77M $50.66M
YoY Change -37.59% -54.86% -44.27%
LONG-TERM ASSETS
Property, Plant & Equipment $387.0K $353.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $23.20M $23.10M $23.10M
YoY Change -8.94% 24.13% 144.06%
Other Assets $500.0K $500.0K $500.0K
YoY Change 222.58% 222.58% 222.58%
Total Long-Term Assets $29.27M $29.38M $25.58M
YoY Change 9.5% 56.58% 117.39%
TOTAL ASSETS
Total Short-Term Assets $38.42M $44.77M $50.66M
Total Long-Term Assets $29.27M $29.38M $25.58M
Total Assets $67.70M $74.15M $76.24M
YoY Change -23.33% -37.13% -25.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $600.0K $400.0K
YoY Change 40.85% 187.08% 4.99%
Accrued Expenses $1.000M $1.000M $1.300M
YoY Change 45.56% 45.77% 91.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.658M $1.720M $1.789M
YoY Change 220.63% 92.18% 68.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.300M $3.400M $700.0K
YoY Change
Total Long-Term Liabilities $3.300M $3.400M $700.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.658M $1.720M $1.789M
Total Long-Term Liabilities $3.300M $3.400M $700.0K
Total Liabilities $5.917M $5.083M $2.469M
YoY Change 613.75% 467.93% 132.7%
SHAREHOLDERS EQUITY
Retained Earnings -$198.3M -$189.6M -$185.9M
YoY Change 15.04% 13.5%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $501.0K $501.0K $3.322M
YoY Change -71.37% 1158.33%
Treasury Stock Shares
Shareholders Equity $61.78M $69.07M $73.77M
YoY Change
Total Liabilities & Shareholders Equity $67.70M $74.15M $76.24M
YoY Change -23.33% -37.13% -25.74%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$8.663M -$3.762M -$7.260M
YoY Change 70.63% 6.42% 301.1%
Depreciation, Depletion And Amortization $20.00K $7.000K
YoY Change
Cash From Operating Activities -$9.920M -$3.991M -$1.860M
YoY Change 387.23% 4.04% -9.18%
INVESTING ACTIVITIES
Capital Expenditures $60.00K $360.0K $1.300M
YoY Change -6600.0%
Acquisitions
YoY Change
Other Investing Activities $4.040M -$18.35M $2.660M
YoY Change -177.69% 82.08% -95.67%
Cash From Investing Activities $3.990M -$18.71M $1.360M
YoY Change -176.73% 85.66% -97.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -$939.0K -820.0K
YoY Change -100.0% -104.94% -456.52%
NET CHANGE
Cash From Operating Activities -9.920M -$3.991M -1.860M
Cash From Investing Activities 3.990M -$18.71M 1.360M
Cash From Financing Activities 0.000 -$939.0K -820.0K
Net Change In Cash -5.930M -$23.64M -1.320M
YoY Change -81.38% -565.65% -102.21%
FREE CASH FLOW
Cash From Operating Activities -$9.920M -$3.991M -$1.860M
Capital Expenditures $60.00K $360.0K $1.300M
Free Cash Flow -$9.980M -$4.351M -$3.160M
YoY Change 390.18% 13.43% 55.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5252517 shares
CY2022Q4 us-gaap Alternative Investment
AlternativeInvestment
23103000 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-05576
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
domh Lower Valuation
LowerValuation
48.16
CY2022Q4 us-gaap Stock Dividends Shares
StockDividendsShares
600000 shares
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0849320
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
725 5th Avenue
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
22nd Floor,
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2023Q1 dei City Area Code
CityAreaCode
(703)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
992-9325
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
DOMH
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4592578 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9533000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33174000 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
24394000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7130000 usd
CY2023Q1 domh Clearing Broker Deposits
ClearingBrokerDeposits
3550000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
745000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
564000 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
301000 usd
CY2023Q1 us-gaap Other Short Term Investments
OtherShortTermInvestments
13000 usd
CY2022Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
13000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6536000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
7474000 usd
CY2022Q4 domh Investment In Field Point Securitie
InvestmentInFieldPointSecuritie
2000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
44771000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50656000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
353000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1850000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1100000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
23103000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
23103000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3619000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
919000 usd
CY2023Q1 us-gaap Security Deposit
SecurityDeposit
458000 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
458000 usd
CY2023Q1 us-gaap Assets
Assets
74154000 usd
CY2022Q4 us-gaap Assets
Assets
76236000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
641000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
447000 usd
CY2023Q1 domh Accrued Salaries And Benefit
AccruedSalariesAndBenefit
732000 usd
CY2022Q4 domh Accrued Salaries And Benefit
AccruedSalariesAndBenefit
1260000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
198000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
82000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
124000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1720000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1789000 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3363000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
680000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
5083000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2469000 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4815597 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5485096 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4755449 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5017079 shares
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
259215000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
262970000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
60148 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
468017 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
501000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3322000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189643000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185881000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
69071000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
73767000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74154000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76236000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3833000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1787000 usd
CY2023Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
1000 usd
CY2022Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
2016000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3834000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3803000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3834000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3803000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
64000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
137000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
179000 usd
CY2023Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-65000 usd
CY2022Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-497000 usd
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
522000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
72000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
268000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3762000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3535000 usd
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
3009000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3762000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6544000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.25
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5305513 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5252517 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
73767000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
5000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
939000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3762000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
69071000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
101595000 usd
CY2022Q1 domh Redemption Of Series P Redeemable Convertible Preferred Stock
RedemptionOfSeriesPRedeemableConvertiblePreferredStock
-3009000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3535000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
95051000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3762000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3535000 usd
CY2023Q1 domh Amortization Of Rightofuse Assets
AmortizationOfRightofuseAssets
-92000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
7000 usd
CY2022Q1 domh Change In Fair Value Of Shortterm Investment
ChangeInFairValueOfShorttermInvestment
886000 usd
CY2022Q1 domh Change In Fair Value Of Longterm Investment
ChangeInFairValueOfLongtermInvestment
-1408000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5000 usd
CY2023Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-56000 usd
CY2022Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-224000 usd
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-130000 usd
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-333000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
64000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
221000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-66000 usd
CY2023Q1 domh Increase Decrease In Prepaid Acquisition Cost
IncreaseDecreaseInPrepaidAcquisitionCost
-301000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-172000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-528000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
6000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
7000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3000 usd
CY2023Q1 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
62000 usd
CY2022Q1 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
179000 usd
CY2022Q1 domh Amortization Of Rightofuse Assets
AmortizationOfRightofuseAssets
usd
CY2022Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-7000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3991000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3836000 usd
CY2023Q1 domh Purchase Of Marketable Securities
PurchaseOfMarketableSecurities
17519000 usd
CY2022Q1 domh Purchase Of Marketable Securities
PurchaseOfMarketableSecurities
27096000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
68000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24662000 usd
CY2022Q1 domh Proceeds From Sale Of Dat Chat Common Shares
ProceedsFromSaleOfDatChatCommonShares
93000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
361000 usd
CY2023Q1 domh Return Of Depositfunding Of Deposit Into A Managed Account Net
ReturnOfDepositfundingOfDepositIntoAManagedAccountNet
1149000 usd
CY2023Q1 domh Purchase Of Convertible Note
PurchaseOfConvertibleNote
-250000 usd
CY2022Q1 domh Purchase Of Shortterm And Longterm Promissory Notes
PurchaseOfShorttermAndLongtermPromissoryNotes
7737000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18711000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10078000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
18991000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
939000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-939000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18991000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23641000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5077000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33174000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65562000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9533000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70639000 usd
CY2022Q1 domh Transfer From Longterm Investment To Marketable Securites
TransferFromLongtermInvestmentToMarketableSecurites
1482000 usd
CY2022Q1 domh Promissory Convertible Note Receivable Conversion Into Common Shares
PromissoryConvertibleNoteReceivableConversionIntoCommonShares
2147000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
3149000 usd
CY2023Q1 domh Less Deposit Previously Transferred In October2022 To Fps
LessDepositPreviouslyTransferredInOctober2022ToFPS
2000000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1149000 usd
CY2023Q1 domh Reverse Stock Split
ReverseStockSplit
30000.00 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3400000 usd
CY2023Q1 us-gaap Deposits
Deposits
100000 usd
CY2021Q3 domh Interest
Interest
1000000 usd
CY2023Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
3400000 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
92000 usd
CY2023Q1 domh Deposits With Clearing Broker Dealer
DepositsWithClearingBrokerDealer
3550000 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
53000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
89000 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
3784000 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
273000 usd
CY2023Q1 us-gaap Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
25000 usd
CY2023Q1 domh Wealth Management Liabilities
WealthManagementLiabilities
62000 usd
CY2023Q1 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
360000 usd
CY2023Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
3424000 usd
CY2023Q1 domh Net Loss
NetLoss
700000 usd
CY2023Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
600000 usd
CY2023Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
300000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
600000 usd
CY2023Q1 domh Realizedloss Gain
RealizedlossGain
56000 usd
CY2022Q1 domh Realizedloss Gain
RealizedlossGain
224000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-130000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-333000 usd
CY2023Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
119000 usd
CY2022Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
60000 usd
CY2023Q1 domh Marketable Securities Gain Losses
MarketableSecuritiesGainLosses
-65000 usd
CY2022Q1 domh Marketable Securities Gain Losses
MarketableSecuritiesGainLosses
-497000 usd
CY2023Q1 us-gaap Alternative Investment
AlternativeInvestment
23103000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1400000 usd
CY2022Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
100000 usd
CY2021Q4 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
250000 shares
CY2021Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1000000 usd
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
1000000 usd
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
2000000 usd
CY2022Q4 domh Per Share
PerShare
0.5
CY2022Q1 us-gaap Payable Investment Purchase
PayableInvestmentPurchase
1500000 usd
CY2023Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
1800000 usd
CY2023Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
250000 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
40000.00 usd
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
24394000 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
24394000 usd
CY2023Q1 domh Shortterm Investments
ShorttermInvestments
13000 usd
CY2023Q1 domh Notes Receivable At Fair Value Current Portion
NotesReceivableAtFairValueCurrentPortion
6536000 usd
CY2023Q1 domh Notes Receivable At Fair Value Noncurrent Portion
NotesReceivableAtFairValueNoncurrentPortion
1850000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
7130000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
7130000 usd
CY2022Q4 domh Shortterm Investments
ShorttermInvestments
13000 usd
CY2022Q4 domh Notes Receivable At Fair Value Current Portion
NotesReceivableAtFairValueCurrentPortion
7474000 usd
CY2022Q4 domh Notes Receivable At Fair Value Noncurrent Portion
NotesReceivableAtFairValueNoncurrentPortion
1100000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
13000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
13000 usd
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
7474000 usd
CY2023Q1 domh Collection Of Principal Outstanding
CollectionOfPrincipalOutstanding
-250000 usd
CY2023Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
62000 usd
CY2023Q1 domh Note Receivable Convergent Convertible Note Noncurrent Portion
NoteReceivableConvergentConvertibleNoteNoncurrentPortion
-750000 usd
CY2022Q1 domh Share Buyback Program Amount
ShareBuybackProgramAmount
3000000 usd
CY2023Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
6536000 usd
CY2022Q4 domh Notes Receivableat Fair Value Non Current Portion
NotesReceivableatFairValueNon-CurrentPortion
1100000 usd
CY2023Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
750000 usd
CY2023Q1 domh Notes Receivable At Fair Value Noncurrent Portion
NotesReceivableAtFairValueNoncurrentPortion
1850000 usd
CY2023Q1 us-gaap Lessee Finance Lease Description
LesseeFinanceLeaseDescription
The initial term of the Company’s Lease is seven (7) years commencing on July 11, 2022 (“Commencement Date).
CY2023Q1 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
12874 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
13502 usd
CY2022Q3 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
49368 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
51868 usd
CY2023Q1 domh Operating Lease Rightofuseassets
OperatingLeaseRightofuseassets
3619000 usd
CY2023Q1 domh Operating Lease Current
OperatingLeaseCurrent
198000 usd
CY2023Q1 domh Operating Lease Long Term1
OperatingLeaseLongTerm1
3363000 usd
CY2023Q1 domh Operating Leases Liability
OperatingLeasesLiability
3561000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2023Q1 us-gaap Lease Cost
LeaseCost
100000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
134 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
134 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
30 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
164 usd
CY2023Q1 domh Shares Cancelled
SharesCancelled
25000 shares
CY2023Q1 domh Change In Fair Value Of Longterm Investment
ChangeInFairValueOfLongtermInvestment
usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
34000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2796000 usd
CY2023Q1 domh Term Of Future Minimum Payments
TermOfFutureMinimumPayments
P5Y
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
365000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
750000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
688000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
688000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
688000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
770000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1166000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5115000 usd
CY2023Q1 domh Less Present Value Discount
LessPresentValueDiscount
-1554000 usd
CY2023Q1 domh Operating Lease Liabilities
OperatingLeaseLiabilities
3561000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
476023 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
602445 shares
CY2023Q1 domh Shares Cancelled
SharesCancelled
644499 shares
CY2023Q1 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
644499 usd
CY2023Q1 domh Share Repurchased
ShareRepurchased
236630 shares
CY2023Q1 domh Amount Of Cost
AmountOfCost
0.9 usd
CY2023Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
3.97
CY2023Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
644499 shares
CY2023Q1 domh Original Cost
OriginalCost
3800000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
8068 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
5.64
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
8068 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
5.64
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31193 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
302.97
CY2022Q4 domh Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractual
P7Y10M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31193 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
302.97
CY2023Q1 domh Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractual
P7Y8M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
25311 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
372
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
10000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
usd
CY2023Q1 us-gaap Excess Capital
ExcessCapital
2900000 usd
CY2023Q1 us-gaap Capital Units Net Amount
CapitalUnitsNetAmount
100000 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
80000.00 usd
CY2022Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
300000 usd
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Dominari Holdings Inc.
CY2022Q4 domh Clearing Broker Deposits
ClearingBrokerDeposits
usd
CY2023Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2023Q1 domh Investment In Field Point Securitie
InvestmentInFieldPointSecuritie
usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2023Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.25
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5305513 shares
CY2023Q1 domh Cancellation Of Common Stock
CancellationOfCommonStock
usd
CY2023Q1 domh Retirement Of Treasury Stock
RetirementOfTreasuryStock
usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022Q1 domh Distribution Of Hoth Common Stock
DistributionOfHothCommonStock
usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
CY2022Q1 domh Increase Decrease In Prepaid Acquisition Cost
IncreaseDecreaseInPrepaidAcquisitionCost
usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
usd
CY2023Q1 domh Proceeds From Sale Of Dat Chat Common Shares
ProceedsFromSaleOfDatChatCommonShares
usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
usd
CY2023Q1 domh Purchase Of Shortterm And Longterm Promissory Notes
PurchaseOfShorttermAndLongtermPromissoryNotes
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2023Q1 domh Transfer From Longterm Investment To Marketable Securites
TransferFromLongtermInvestmentToMarketableSecurites
usd
CY2023Q1 domh Promissory Convertible Note Receivable Conversion Into Common Shares
PromissoryConvertibleNoteReceivableConversionIntoCommonShares
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000012239

Files In Submission

Name View Source Status
domh-20230331_def.xml Edgar Link unprocessable
0001213900-23-038233-index-headers.html Edgar Link pending
0001213900-23-038233-index.html Edgar Link pending
0001213900-23-038233.txt Edgar Link pending
0001213900-23-038233-xbrl.zip Edgar Link pending
domh-20230331.xsd Edgar Link pending
f10q0323ex10-1_dominarihold.htm Edgar Link pending
f10q0323ex10-2_dominarihold.htm Edgar Link pending
f10q0323ex31-1_dominarihold.htm Edgar Link pending
f10q0323ex32-1_dominarihold.htm Edgar Link pending
f10q0323_dominarihold.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
domh-20230331_cal.xml Edgar Link unprocessable
domh-20230331_lab.xml Edgar Link unprocessable
domh-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0323_dominarihold_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending